Skip to main content
. 2022 Oct 21;8(1):101109. doi: 10.1016/j.adro.2022.101109

Table 2.

Female patient characteristics

Female
patient number Age (y) Tumor stage Tumor location
1 57 T3 N1 Lower
2 69 T3 N2 Mid
3 62 T3 N2 Mid
4 59 T2 N1 Lower
5 45 T3 N2 Upper
6 51 T3 N2 Mid
7 55 T2 N1 Mid
8 71 T3 N2 Mid
9 63 T3 N2 Mid
10 69 T2 N1 Lower
11 71 T3 N2 Upper
12 62 T3 N2 Mid
13 66 T3 N3 Mid
14 42 T3 N2 Mid
15 67 T3 N1 Upper
16 72 T2 N1 Mid